Filing Details
- Accession Number:
- 0000014272-22-000090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-18 17:50:49
- Reporting Period:
- 2022-03-16
- Accepted Time:
- 2022-03-18 17:50:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1677618 | Rupert Vessey | 430 E. 29Th Street 14Th Floor New York NY 10016 | Evp, Research & Early Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Disposition | 2022-03-16 | 31,331 | $69.27 | 46,308 | No | 4 | S | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2022-03-16 | 21,288 | $66.35 | 67,596 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2022-03-16 | 5,294 | $55.52 | 72,890 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2022-03-16 | 12,233 | $54.29 | 85,123 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2022-03-16 | 8,490 | $38.41 | 93,613 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2022-03-16 | 43,228 | $69.23 | 50,385 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2022-03-16 | 21,288 | $0.00 | 21,288 | $66.35 |
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2022-03-16 | 12,233 | $0.00 | 12,233 | $54.29 |
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2022-03-16 | 5,294 | $0.00 | 5,294 | $55.52 |
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2022-03-16 | 8,490 | $0.00 | 8,490 | $38.41 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2027-05-01 | No | 4 | M | Direct | |
0 | 2027-10-30 | No | 4 | M | Direct | |
0 | 2028-01-29 | No | 4 | M | Direct | |
8,491 | 2028-10-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.10 Par Value | 632 | Indirect | BMS Savings and Investment Program |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.26 to $69.305, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- 43,228 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.16 to $69.33, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Based on recent 401(k) plan statement.
- All of the shares are currently exercisable.